Pierre Kemula
Director of Finance/CFO at CUREVAC N.V.
Net worth: 182 520 $ as of 2024-04-29
Network origin in Pierre Kemula first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
25
| Public Company | Pharmaceuticals: Major | 25 |
25
| Public Company | Pharmaceuticals: Major | 25 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.
18
| Subsidiary | Biotechnology | 18 |
| Public Company | Medical Specialties | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Pierre Kemula via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Director of Finance/CFO | |
| ESSEC Business School | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| MORPHOSYS AG | Biotechnology | Director/Board Member Corporate Officer/Principal Public Communications Contact | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Gsk Biologicals
 Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Director/Board Member | |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| VALNEVA | Biotechnology | Director/Board Member Director/Board Member | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Compliance Officer | |
| AIR LIQUIDE | Chemicals: Specialty | Human Resources Officer Chief Tech/Sci/R&D Officer | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer | ||
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
| AgroParisTech | College/University | Graduate Degree Graduate Degree | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member | |
BESIX Group NV
 BESIX Group NV Engineering & ConstructionIndustrial Services BESIX Group NV engages in the provision of construction and engineering solutions. Its business units include real estate, contracting, and concessions and assets. The real estate business realizes residential and office buildings in prime locations. The Contracting business comprises buildings, marine works, infrastructure, industry, environment; and sports and leisure. The concessions and assets business acquires, invests, operates, and maintains projects. The company was founded in 1909 and is headquartered in Woluwe-Saint-Lambert, Belgium. | Engineering & Construction | Chairman Director/Board Member | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree Doctorate Degree | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chairman Corporate Officer/Principal | |
| BNP PARIBAS FORTIS SA | Major Banks | Director/Board Member Director/Board Member | |
| GROUPE BRUXELLES LAMBERT SA | Financial Conglomerates | Director/Board Member Director/Board Member | |
| TIGENIX NV | Medical Specialties | Chairman Chairman | |
BePharBel Manufacturing SA
 BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology BePharBel Manufacturing SA manufactures and distributes pharmaceutical products. Its products include drugs, tuberculosis and food supplements and cosmetics. The company was founded on March 26, 2012 and is headquartered in Courcelles, Belgium. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
OncoDNA SA
 OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chairman Director/Board Member | |
Vaxxilon AG
 Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The private company is based in Reinach, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member | |
| Leem | Director/Board Member Founder | ||
Servier SAS
 Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| IMMATICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Chief Executive Officer | |
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The private company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| COSMO PHARMACEUTICALS N.V. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Universität zu Köln | College/University | Doctorate Degree Doctorate Degree | |
| Université Paris II Panthéon Assas | College/University | Graduate Degree Graduate Degree | |
| ABIVAX | Pharmaceuticals: Other | Chief Executive Officer Director/Board Member | |
Ipsen International GmbH
 Ipsen International GmbH Industrial MachineryProducer Manufacturing Ipsen International GmbH manufactures and distributes furnaces and plant systems. Its products include sealed quench furnaces; chamber and multi-purpose chamber furnaces; horizontal and vertical furnaces; EcoFire system; HydroNit Sensor; HybridCarb; and EndoSave system. The firm also provides software processes such as Carb-o-Prof 4.0, AutoMag, Vacu-Prof, and Conti-Control. The company was founded by Harold Ipsen in 1957 and is headquartered in Kleve, Germany. | Industrial Machinery | Corporate Officer/Principal Public Communications Contact | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Ipsen Pharma SA
 Ipsen Pharma SA Pharmaceuticals: MajorHealth Technology Ipsen Pharma SA manufactures and distributes pharmaceutical products. It supplies products to the therapeutic areas such as oncology, endocrinology, and neuromuscular disorders. The firm also develops drugs for gastroenterology, cognitive disorders, and cardiovascular diseases. Ipsen Pharma is headquartered in Sant Feliu de Llobregat, Spain. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal |
Statistics
International
| France | 16 |
| Germany | 14 |
| Belgium | 9 |
| United States | 7 |
| Switzerland | 4 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 5 |
| Process Industries | 2 |
Operational
| Director/Board Member | 256 |
| Corporate Officer/Principal | 140 |
| Chairman | 85 |
| Chief Executive Officer | 59 |
| Independent Dir/Board Member | 52 |
Most connected contacts
| Insiders | |
|---|---|
| Jean-Luc Bélingard | 40 |
| Friedrich von Bohlen und Halbach | 36 |
| Baron Jean Stéphenne | 36 |
| Marc M. P. de Garidel | 31 |
| Hans Tanner | 24 |
| Alexandre LeBeaut | 22 |
| Craig Tooman | 22 |
| Maïlys Ferrère | 21 |
| Christel Bories | 21 |
| Claude Bertrand | 20 |
| Mathias Hothum | 19 |
| Martha Heitzmann-Crawford | 18 |
| James A. Reinstein | 17 |
| Klaus Schollmeier | 17 |
| Carol Xueref | 17 |
- Stock Market
- Insiders
- Pierre Kemula
- Company connections